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 Interoffice Memorandum 
 
SCHOOL OF PHARMACY  
OFFICE OF THE DEAN  
University, MS 38677 
Phone: (662) 915-7265 Fax: (662) 915-5704 
 
TO:  All School of Pharmacy Personnel 
 
FROM:  Charles D. Hufford, Associate Dean for Research and Graduate Programs 
 
DATE: November 16, 2000 
 
SUBJECT:  Research News (#4) 
               
 
The following GRANTS have recently been awarded: 
1. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Design, Econ. Synth. and Testing of Nontoxic 
Artemisinin Analogs (World Health Organization), $43,490 – (Year 3). 
2. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Rational Design and Synthesis of Novel Drugs for 
the Treatment of Emerging Infectious Diseases (CDC), $1,500,000 – 10/1/ -9/30/01. 
3. Dr. Mitchell Avery (P.I. – Medicinal Chemistry) – Development and Testing of New Antimalarial 
Drugs (CDC), $5,000,000 – 9/1/00-8/31/01. 
4. Dr. Alice M. Clark (P.I. – RIPS/NCNPR); Dr. Ikhlas Khan (Co-P.I. – RIPS/NCNPR); Ms. Allyson 
Best (Co-P.I. – RIPS/NCNPR); and Dr. Charles Burandt (Co-P.I. – RIPS/NCNPR) – Natural 
Products Initiative (Alcorn State University), $700,000 – / 1/ -6/30/01. 
5. Dr. Alice M. Clark (P.I. – RIPS/NCNPR); Dr. Larry Walker (Co-P.I. – RIPS/NCNPR); and Dr. 
Charles Burandt (Co-P.I. – RIPS/NCNPR) – Phytomedicines at the University of Mississippi (CDC), 
$1,823,000 – 9/30/00-9/29/01. 
6. Dr. Alice M. Clark (P.I. – RIPS/NCNPR) – NCNPR/NPURU Development of Natural Products from 
Plants and Microbes for Replacement of Synthetic Pesticides, Amendment 5 (USDA), $10,140.
7. Dr. Mahmoud ElSohly (P.I. – RIPS/NCNPR) – Appropriate Quality Control Procedures of Herbal 
Drugs in Egypt (U.S. Agency for International Development/Funds via Foreign Relations 
Coordination Unit, Egypt), $40,000. 
8. Dr. Mark Hamann (P.I. – Pharmacognosy); Dr. Mitch Avery (Co-P.I. – Medicinal Chemistry); and 
Dr. Jordan Zjawiony (Co-P.I. – Pharmacognosy) – AntiAIDS Agents from Marine Natural Products 
(PHS, NIAID, RO1), $252,000 – 12/01/00-11/30/01. 
9. Dr. Mark Hamann (P.I. – Pharmacognosy) – Novel Approaches to the Characterization of 
Antiinfective Agents – Year 3 (NIH/NIAID), $91,908. 
  
210. Dr. Ikhlas Khan (P.I. – RIPS/NCNPR) and Dr Alison Nimrod (Co-P.I. – RIPS/NCNPR) – 
Therapeutic Ratios of Herbs: Ginkgo as a Model (Center for Alternative Medicine Research and 
Education, Harvard), $82,121 – 9/ /99-8/31/01. 
11. Dr. David McCaffrey (P.I. – Pharmacy Administration) – The State of Pharmacy Affairs Departments 
within U.S. Pharmaceutical Companies: An Assessment of Structure, Role and Activities (Amgen), 
$10,000 – 6/21/00-6/20/02. 
12. Dr. David McCaffrey (P.I. – Pharmacy Administration) – Opportunities and Challenges Associated 
with the Implementation of Pharmaceutical Care in Mississippi (Saint Anthony Educational 
Foundation, Inc.) – 5,000.  
13. Dr. Dale Nagle (P.I. – Pharmacognosy) and Dr. Dennis Feller (Co-P.I.– Pharmacology) – Discovery 
of New Drugs that Target Peroxisomal Proliferator-Activated Receptor-gamma (PPAR-gamma) for 
the Treatment of Breast Tumors (Dept. of Defense/2000 Breast Cancer Research Program: Concept 
Award – U.S. Army Medical Research Acquisition Activity), $72,000 – 10/1/00-9/30/01. 
14. Dr. Dale Nagle (P.I. – Pharmacognosy) – Discovery of New Angiogensis Inhibitors to Treat Cancer 
(American Society of Pharmacognosy Foundation), $2,500. 
15. Dr. Dale Nagle (P.I. – Pharmacognosy) – Novel Fungicidal Agents to Control Plant Pathogens 
(American Society of Pharmacognosy) - $5,000. 
16. Dr. Marc Slattery (P.I. – Pharmacognosy) – Marine Biotechnology: Antimicrobial Natural Products 
from Cave Sponges (Perry Institute for Marine Science) - $17,749. 
17. Dr. Larry Walker (P.I. – RIPS/NCNPR) and Dr. Alice Clark (Co-P.I. – RIPS/NCNPR) – Natural 
Products Acting via New Anti-Fungal Targets (NIAID/NCI/Georgetown), $168,744 – 9/1/00-
8/31/01. 
18. Dr. Larry Walker (P.I. – RIPS/NCNPR) – Preclinical Development of a New Drug for PCP and 
Malaria: Research Institute (NIH: Subcontract ElSohly Laboratories, Inc.) - $192,031 – 10/1/99-
9/30/01. 
 
The following PUBLICATIONS  have appeared: 
1. R. Bekker, D. Ferreira, K.J. Swart and E.V. Brandt – “Biflavonoids. Part 5: Structure and 
Stereochemistry of the First Bibenzofuranoids”, Tetrahedron, 56, pp. 5297-5302, 2000. 
2. J.S. Williamson and C.M. Wyandt – “Chlamydia: The Silent STD”, Drug Topics, pp. 34- 3, 
September 4, 2000. 
3. D.B. Huggett, D.S. Block, I.A. Khan, J.C. Allgood and W.H. Benson – “E vironmental 
Contaminants in the Botanical Dietary Supplement Ginseng and Potential Human Risk”,  and 
Ecological Risk Assessment, 6, pp. 767- 76, 2000. 
4. J.S. Williamson and C.M. Wyandt – “Helicobacter pylori: Causes and Cures”, Drug Topics, pp. 86-
95, November 1, 1999. 
5. S.A. Ross – Book Review – Medicinal and Aromatic Plants – Industrial Profiles: Cannabis: The 
Genus Cannabis Edited by D.T. Brown, J. Nat. Prod., 2000. 
6. D.G. Nagle, Y.D. Zhou, P.U. Park, V.J. Paul, I. Rajbhandari, C.J.G. Duncan and D.S. Pasco – “A 
New Indanone from the Marine Cyanobacterium Lyngbya majuscula That Inhibits Hypoxia-Induced 
Activation of the VEGF Promoter in Hep3B Cells”, J. Nat. Prod., 63, pp. 1431- 433, 2000. 
7. J.S. Williamson and C.M. Wyandt – “The Pharmacist as Vitamin Expert”, Drug Topics, pp. 76-85, 
August 16, 1999. 
8. J.P.J. Marais, I.M. Harvey, E.V. Brandt and D. Ferreira – “Polyphenols, Condensed Tannins, and 
Other Natural Products in Onobrychis viciifolia (Sainfoin)”, J. Agric. Food Chem., 48, pp. 3440-
3447, 2000. 
39. M. Ganzera, E. Bedir and I.A. Khan – “Separation of Cimicifuga racemosa Triterpene Glycosides by 
Reversed Phase High Performance Liquid Chromatography and Evaporative Light Scattering 
Detection”, Chromatographia, 52, pp. 301-304, 2000. 
10. J.S. Williamson and C.M. Wyandt – “What to Tell Your Patien s About Antioxidants”, Drug Topics, 
pp. 120-129, December 6, 1999. 
 
The following TECHNOLOGY TRANSFER  transactions have occurred: 
In the interest of protecting confidential information, the titles of invention disclosures and patent 
applications will not be published until after a patent has been issued.  Inventors outside of the 
School of Pharmacy will not be published until after a patent has been issued. 
 
INVENTION DISCLOSURES FILED IN 2000 
· Mahmoud ElSohly, Samir Ross, et al. 
· Hamidreza Ghandehari, Anjan Nan, Dhammika Nanayakkara 
· John Buolamwini 
· Alicia Bouldin, Mike Fortenberry, Noel Wilkin
· N. P. Dhammika Nanayakkara and Kevin Shrader 
· Isamu Katsuyama, David Stewart, and Jordan Zjawiony 
 
PATENT APPLICATIONS PENDING APPROVAL 
· David S. Pasco, Nirmal Pugh, Ma moud ElSohly, Samir Ross 
· David S. Pasco, Nirmal Pugh, Mahmoud ElSohly, Samir Ross 
· Mark T. Hamann, Khalid El Sayed et.al. 
· Mitchell A. Avery 
· David S. Pasco et. al. 
· John K. Buolamwini et. al. 
· Mahmoud ElSohly, Samir Ross, et al 
· N. P. Dhammika Nanayakkara et. al.
 
RECENT PATENTS GRANTED: 
“1,2-Dithiolane Derivatives”  
Mitchell Avery et.al. 
US Patent 6,127,394  Issued: October 3, 2000. 
 
“Enhanced Yield Of Podophyllotoxin From Natural Products Through In Situ Conversion Methods”  
Camilo Canel; Franck E. Dayan; ; Rita M. Moraes; Charles L. Burandt;  
US Patent 6,143,304 Issued: November 7, 2000. 
 
The following SPECIAL ANNOUNCEMENTS  are also listed: 
· Dr. Walt Chambliss was elected Chair-Elect of Basic Sciences in the APRS section of APhA. 
· Dr. Walt Chambliss has been invited to give a presentation at the 4th Annual Consumer and 
Diversified Products Conference that will be held during the annual Controlled Release Society 
Meeting in June 2001 in San Diego.  The requested title for his presentation is “Dietary Supplements 
and Controlled Release”. 
· Dr. Bruce Parks has been elected a Fellow of the American College of Clinical Pharmacy.  Fellowship 
in the College recognizes and rewards the highest levels of excellence in the practice and science of 
Clinical Pharmacy.  The awarding of Fellow status is the highest honor the College can bestow on its 
4members.  Dr. Parks has helped establish, by example, to people both within and outside the College, 
the definition of ACCP Fellowship. 
 
Please continue to send me important research and graduate information so that I might share it with your 
faculty colleagues.  THIS INFORMATION IS NOW BEING POSTED ON THE SCHOOL OF 
PHARMACY WEB PAGE!  Thank you. 
 
cc: Interim Dean Robert D. Sindelar 
 Ms. Barbara Lago 
 Ms. Beverly Urbanek 
 Ms. Dabney Weems  
